WuXi PharmaTech, China's leading provider of pharmaceutical R&D outsourcing services announced that it has begun moving the first group of scientists to its state-of-the-art Tianjin research facility, which first became operational in December, 2006. Located in the Tianjin Economic and Technical Development Zone (TEDA) (also known as Tai Da), Tianjin PharmaTech is a wholly owned subsidiary of WuXi PharmaTech Co., Ltd.

The new facility aptly compliments the Shanghai research campus with 130,000 sq. ft. of new laboratory space.

Tianjin PharmaTech boasts an even higher advanced equipment ratio than WuXi PharmaTech's other already very well equipped facilities.

The TEDA Development Zone was one of China's first state-level development areas and now encompasses an area of over 27 sq. km. With special support for high-tech companies, TEDA and Tianjin are an ideal location for WuXi PharmaTech to plant its seed of future growth.

Often referred to as the ''Gate of Beijing'', Tianjin is China's third largest city and offers numerous high quality universities. Drawing from these universities and those of nearby Beijing, Tianjin PharmaTech will benefit from a deep talent pool of qualified researchers.

Source:未知